ETFs in Focus on Bayer's Bet on Gene Therapy
October 30, 2020 at 00:58 AM EDT
Merger and acquisition activities have heated up in recent months and the niche spaces are in the limelight. After the telemedicine industry, gene therapy stocks jumped on the bandwagon.